As 2026 unfolds, the global oncology community is awaiting the primary endpoint data from a series of high-stakes clinical trials focusing on macrophage-mediated tumor clearance. With the Indian Council of Medical Research recently updating its guidelines for biological immunotherapies, researchers are seeing a surge in patient enrollment for studies that target the CD47 protein. These trials...
จองคิวบริการ
NR tours
Youplay
NR shop
NR jobs
facebook th
Spanish 
thai
English
French
Portuguese
Italiano
Romaian
Portuguese (Brazil)
china